Addressing Cell Source & Model Complexity in In Vitro BBB Systems to Enable Physiologically Relevant Models that Accelerate CNS Delivery & Drug Screening
- Evaluate limitations of current cell sources and strategies toimprove BBB model fidelity
- Explore how multi-cellular enhances physiological relevance
- Highlight emerging assays and engineering tools that improvedrug delivery assessment across in vitro BBB models